David Lemus

Insider Reports History

Location
San Diego, CA
Signature
/s/ Rhonda Hellums, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David Lemus:

Company Role Class Num Shares Value Price $ Report Date Ownership
Scilex Holding Co Director Common Stock 2,000 $1,800 $0.9000 17 Oct 2024 Direct
Sorrento Therapeutics, Inc. Director Stock option (right to buy) 250,000 30 Aug 2021 Direct
Scilex Holding Co Director Nonstatutory Stock Option (right to buy) 100,000 15 Mar 2024 Direct
Silence Therapeutics plc Director Share Option (Right to Buy) 90,000 02 Jan 2026 Direct

Insider Reports Filed by David Lemus

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SLN Silence Therapeutics plc 02 Jan 2026 1 $0 4 Director 06 Jan 2026, 16:15
SLN Silence Therapeutics plc 02 Jan 2025 1 $0 4 Director 06 Jan 2025, 16:15
SLN Silence Therapeutics plc 02 Jan 2025 0 $0 3 Director 02 Jan 2025, 16:29
SCLX Scilex Holding Co 17 Oct 2024 1 +$1,800 4 Director 18 Oct 2024, 09:10
SCLX Scilex Holding Co 15 Mar 2024 1 $0 4 Director 26 Jun 2024, 21:29
SCLX Scilex Holding Co 17 Jan 2023 1 $0 4 Director 17 Jan 2023, 16:28
SCLX Vickers Vantage Corp. I 10 Nov 2022 0 $0 3 Director 15 Nov 2022, 17:26
SRNEQ Sorrento Therapeutics, Inc. 30 Aug 2021 1 $0 4 Director 30 Aug 2021, 20:13